Second Sight Medical Products, Inc.(NASDAQ : EYES)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | 3.41% | 494.36 | 1.0% | $778.78m | |
| DHR | Danaher Corp. | 2.22% | 242.56 | 0.7% | $647.76m | |
| MDT | Medtronic Plc | 1.57% | 125.85 | 0.6% | $635.61m | |
| ABT | Abbott Laboratories | 1.98% | 123.90 | 0.8% | $617.22m | |
| ALGN | Align Technology, Inc. | 1.90% | 606.23 | 6.3% | $364.21m | |
| ISRG | Intuitive Surgical, Inc. | 2.40% | 804.72 | 2.3% | $355.09m | |
| NVCR | NovoCure Ltd. | 6.90% | 198.83 | 6.8% | $305.81m | |
| SYK | Stryker Corp. | 1.85% | 256.96 | 1.3% | $305.67m | |
| BDX | Becton, Dickinson & Co. | 3.28% | 258.02 | 1.0% | $297.83m | |
| DXCM | DexCom, Inc. | 2.15% | 399.49 | 7.8% | $278.71m | |
| BSX | Boston Scientific Corp. | 2.98% | 40.85 | 1.0% | $257.04m | |
| IDXX | IDEXX Laboratories, Inc. | 2.78% | 528.46 | 3.7% | $233.25m | |
| BAX | Baxter International, Inc. | 1.36% | 85.79 | 1.8% | $227.71m | |
| EW | Edwards Lifesciences Corp. | 1.98% | 87.96 | 0.4% | $222.64m | |
| A | Agilent Technologies, Inc. | 0.95% | 133.22 | 1.6% | $194.87m |
Company Profile
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It offers Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device intended to provide artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.